Advanced Biotechnologies Inc Releases New EBV and HSV-1 Quantitated Viral Load Controls

COLUMBIA, Md. - June 26, 2013 - PRLog -- ABI’s new Quantitated Viral Load Controls are intended for use in nucleic acid extraction and amplification procedures alongside unknown samples to determine extraction efficiency, measure the viral load of unknown samples, and validate, monitor, and troubleshoot various molecular testing procedures. Additionally, these new products are useful in training laboratory personnel, developing and validating new molecular testing methods, and in spiking buffers/media to simulate unknown test samples.

The finished products contain purified, whole virus particles suspended in TNE with 0.1% sodium azide at a known concentration of 1.5 x10⁷ virus particles (vp)/ml. Testing methods should include an extraction step to release viral DNA, followed by quantitation of the viral DNA. Viral DNA can be quantitated by real-time PCR using ABI’s Quantitated DNA PCR Controls and Primers.  

About Advanced Biotechnologies Inc (ABI):

Since 1982, ABI has produced and supplied innovative virology products and services to researchers and manufacturers worldwide. ABI offers a wide range of standard and custom products and services, including large-scale in vitro production of HIV and other viruses. For more information about ABI’s capabilities, visit www.abionline.com.

For more information about EBV (B95-8 Strain) Quantitated Viral Load Control (Catalog No. T9-107-175) and HSV-1 (MacIntyre Strain) Quantitated Viral Load Control (Catalog No. T9-108-175), or any of ABI’s Standard or Quantitated PCR products, contact your local ABI distributor or contact ABI directly:

Advanced Biotechnologies Inc
9108 Guilford Road
Columbia MD 21046–2701
800–426–0764 International: +1 410–792–9779
info@abionline.com